高雄長庚紀念醫院解剖病理科

返回首頁 > 醫師介紹

姓名：	黃琬婷(Huang Wan-Ting)

學歷：	中山醫學院醫學系, M.D. 1999

經歷：	2015.08~迄今高雄長庚紀念醫院檢驗醫學科主任 2003~迄今高雄長庚紀念醫院解剖病理科主治醫師 2008~2009 美國休士頓T he Methodist Hospital 研究員 1999~2003 高雄長庚紀念醫院解剖病理科住院醫師

現職：	檢驗醫學科負責醫師/副教授

教職：	長庚大學兼任助理教授

信箱：

研究計畫：

近期研究計劃:

2017.08~2018.07 科技部#106-2314-B-182A-135- CUL4A透過自噬信號系統調節肝內膽管細胞癌內環境恆定和上皮-間質之間轉化相關生物病理之研究
2016.08~2017.07科技部#105-2320-B-182A-010 CUL4A與肝內膽管細胞癌轉移和蛋白質代謝相關生物病理之研究
2015.08~2016.07 科技部#104-2320-B-182A-004 CUL4A與肝內膽管細胞癌轉移相關生物病理之研究

重要著作：

代表著作:

<ol>
	<li>Shao-Wen Weng, Ting-Ting Liu, Hock-Liew Eng, Huey-Ling You and Wan-Ting Huang. Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma. Pathology and Oncology Research 2021 Feb; <a href="https://doi.org/10.3389/pore.2021.602714">https://doi.org/10.3389/pore.2021.602714</a> . (Corresonding author)</li>
	<li>Huang WT, Lu HI, Wang YM, Chen YH, Lo CM, Lin WC, Lan YC, Tseng  LH and Li SH. Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy. J. Clin. Med. 2019, 8, 1864 (First author)</li>
	<li>Lee PH, Weng SW, Liu TT, You HL, Liao CK, Wang MC, Huang WT. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.  Exp Mol Pathol 2019 Oct;110:104294. (Corresonding author)</li>
	<li>Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT*. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol<a href="https://www.ncbi.nlm.nih.gov/pubmed/29885407" title="Human pathology.">.</a> 2018 Oct;80:145-151. (SCI; IF= 3.125; Pathology 19/79) (Corresponding author)</li>
	<li>You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT*. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma. Oncol Lett. 2018 Oct;16(4):5505-5511. (SCI; IF= 1.664; Oncology 193/222) (Corresponding author)</li>
	<li>Huang GK, Liu TT, Weng SW, You HL, Wei YC, Chen CH, Eng HL, Huang WT*. CUL4A Overexpression as an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. BMC Cancer (2017) 17:395 DOI 10.1186/s12885-017-3389-z (SCI; IF= 3.288; Oncology 106/222) (Corresponding author)</li>
	<li>You HL, Huang WT*, Liu TT, Weng SW, Eng HL. Mutations of candidate tumor suppressor genes at chromosome 3p in intrahepatic cholangiocarcinoma. Exp Mol Pathol. 2017 Dec;103(3):249-254 (SCI; IF= 2.423; Pathology 25/79) (Co-first author)</li>
	<li>Ting-Ting Liu, Shao-Wen Weng, Ming-Chung Wang, Wan-Ting Huang*. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS 2016 Mar 14;124(3):216-20. (SCI; IF= 1.933; Pathology 37/78)</li>
	<li>Ting-Ting Liu, Huey-Ling You, Shao-Wen Weng, Yu-Ching Wei, Hock-Liew Eng and Wan-Ting Huang*. Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. PLoS One. 2015 Dec 18;10(12) (SCI; IF=3.057; Multidisciplinary sciences 11/63)</li>
	<li>Wan-Ting Huang, Shao-Wen Weng, Yu-Ching Wei, Huey-Ling You, Jui-Tzu Wang, Hock-Liew Eng*. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol 2014; 7(10):6841-6851 (SCI; IF= 1.891; Pathology 40/75)</li>
	<li>Wan-Ting Huang and Shih-Sung Chuang*. High MET gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma. Diagnostic Pathology 2013;  8:16 (SCI; IF=2.597; Pathology 24/75)</li>
	<li>Huey-Ling You, Shao-Wen Weng , Shau-Hsuan Li , Yu-Ching Wei , Jim Jinn-Chyuan Sheu, Chih-Mei Chen  and Wan-Ting Huang*. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma. EXP MOL PATHOL 2012 (accept) (SCI; IF= 2.986; Pathology 20/76)</li>
	<li>Wei Chang, Han-Ku Chen, Ming-Chun Ma, Wan-Ting Huang*. Anaplastic Large Cell Lymphoma With Paraneoplastic Leukocytosis: A Clinicopathological  Analysis Of Five Cases.  AMPIS 2011 119: 194-801(SCI; IF= 1.944; Pathology 38/76)</li>
	<li>Huang WT, Hsu YH, Yang SF, Chuang SS*. Primary Gastrointestinal Follicular Lymphoma: A Clinicopathologic Study of 13 Cases From Taiwan. J Clin Gastroenterol 2008; 42; 997-1002 (SCI; IF= 2.938; Gastroenterology 18/50)</li>
	<li>Huang WT, Chuang SS, Huang CC, Lu CL, Eng HL*. Primary diffuse large B-cell lymphoma of the gallbladder with cholelithiasis masquerading as acute cholecystitis: case report and literature review. N Z Med J. 2007 Mar 23;120(1251):80-7.</li>
	<li>Wan-Ting Huang, Shao-Wen Weng, Chao-Cheng Huang, Huei-Chiou Lin, Po-Chin Tsai, Jiin-Haur Chuang*. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway. AMPIS 2012 Nov; 120(11):872-81 (SCI; IF= 2.042; Pathology 35/75)</li>
</ol>

代表著作:

Shao-Wen Weng, Ting-Ting Liu, Hock-Liew Eng, Huey-Ling You and Wan-Ting Huang. Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma. Pathology and Oncology Research 2021 Feb; https://doi.org/10.3389/pore.2021.602714 . (Corresonding author)
Huang WT, Lu HI, Wang YM, Chen YH, Lo CM, Lin WC, Lan YC, Tseng LH and Li SH. Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy. J. Clin. Med. 2019, 8, 1864 (First author)
Lee PH, Weng SW, Liu TT, You HL, Liao CK, Wang MC, Huang WT. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment. Exp Mol Pathol 2019 Oct;110:104294. (Corresonding author)
Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT*. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol. 2018 Oct;80:145-151. (SCI; IF= 3.125; Pathology 19/79) (Corresponding author)
You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT*. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma. Oncol Lett. 2018 Oct;16(4):5505-5511. (SCI; IF= 1.664; Oncology 193/222) (Corresponding author)
Huang GK, Liu TT, Weng SW, You HL, Wei YC, Chen CH, Eng HL, Huang WT*. CUL4A Overexpression as an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. BMC Cancer (2017) 17:395 DOI 10.1186/s12885-017-3389-z (SCI; IF= 3.288; Oncology 106/222) (Corresponding author)
You HL, Huang WT*, Liu TT, Weng SW, Eng HL. Mutations of candidate tumor suppressor genes at chromosome 3p in intrahepatic cholangiocarcinoma. Exp Mol Pathol. 2017 Dec;103(3):249-254 (SCI; IF= 2.423; Pathology 25/79) (Co-first author)
Ting-Ting Liu, Shao-Wen Weng, Ming-Chung Wang, Wan-Ting Huang*. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS 2016 Mar 14;124(3):216-20. (SCI; IF= 1.933; Pathology 37/78)
Ting-Ting Liu, Huey-Ling You, Shao-Wen Weng, Yu-Ching Wei, Hock-Liew Eng and Wan-Ting Huang*. Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. PLoS One. 2015 Dec 18;10(12) (SCI; IF=3.057; Multidisciplinary sciences 11/63)
Wan-Ting Huang, Shao-Wen Weng, Yu-Ching Wei, Huey-Ling You, Jui-Tzu Wang, Hock-Liew Eng*. Genome-wide single nucleotide polymorphism array analysis reveals recurrent genomic alterations associated with histopathologic features in intrahepatic cholangiocarcinoma. Int J Clin Exp Pathol 2014; 7(10):6841-6851 (SCI; IF= 1.891; Pathology 40/75)
Wan-Ting Huang and Shih-Sung Chuang*. High MET gene copy number predicted poor prognosis in primary intestinal diffuse large B-cell lymphoma. Diagnostic Pathology 2013; 8:16 (SCI; IF=2.597; Pathology 24/75)
Huey-Ling You, Shao-Wen Weng , Shau-Hsuan Li , Yu-Ching Wei , Jim Jinn-Chyuan Sheu, Chih-Mei Chen and Wan-Ting Huang*. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma. EXP MOL PATHOL 2012 (accept) (SCI; IF= 2.986; Pathology 20/76)
Wei Chang, Han-Ku Chen, Ming-Chun Ma, Wan-Ting Huang*. Anaplastic Large Cell Lymphoma With Paraneoplastic Leukocytosis: A Clinicopathological Analysis Of Five Cases. AMPIS 2011 119: 194-801(SCI; IF= 1.944; Pathology 38/76)
Huang WT, Hsu YH, Yang SF, Chuang SS*. Primary Gastrointestinal Follicular Lymphoma: A Clinicopathologic Study of 13 Cases From Taiwan. J Clin Gastroenterol 2008; 42; 997-1002 (SCI; IF= 2.938; Gastroenterology 18/50)
Huang WT, Chuang SS, Huang CC, Lu CL, Eng HL*. Primary diffuse large B-cell lymphoma of the gallbladder with cholelithiasis masquerading as acute cholecystitis: case report and literature review. N Z Med J. 2007 Mar 23;120(1251):80-7.
Wan-Ting Huang, Shao-Wen Weng, Chao-Cheng Huang, Huei-Chiou Lin, Po-Chin Tsai, Jiin-Haur Chuang*. Expression of Toll-like receptor9 in diffuse large B-cell lymphoma: further exploring CpG oligodeoxynucleotide in NFκB pathway. AMPIS 2012 Nov; 120(11):872-81 (SCI; IF= 2.042; Pathology 35/75)

[ 返回上一頁 ]